Selecting Antiplatelet Therapy at the Time of Percutaneous Intervention for an Acute Coronary Syndrome: Weighing the Benefits and Risks of Prasugrel Versus Clopidogrel [Original Articles]

Conclusions— The expected benefits and risks of prasugrel versus clopidogrel depend highly on patient characteristics. The use of risk models could support individualized thienopyridine selection to maximize the benefits and safety of these drugs.

http://circoutcomes.ahajournals.org/cgi/content/short/6/1/27?rss=1

Source: Circulation: Cardiovascular Quality and Outcomes - January 15, 2013 Category: Cardiology Authors: Salisbury, A. C., Wang, K., Cohen, D. J., Li, Y., Jones, P. G., Spertus, J. A. Tags: Platelet function inhibitors, Other Treatment, Acute coronary syndromes, Acute myocardial infarction Original Articles Source Type: research